Giovanni Schinzari
机构: Università Cattolica del Sacro Cuore
每年引用次数
引用次数
引用: 3,640
H-指数: 34
I10-指数 : 79
出版物: 192
Direct antiproliferative effect of triptorelin on human breast cancer cells.
F. Iacopino , G. Sica , L. Marini , G. Mantovani
Anticancer Research 14 1881 -1885
13
1994
Phase II study of cetuximab in combination with cisplatin and docetaxel as first-line treatment in patients with locally advanced/metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma
F. Rojas Llimpe , A. Martoni , V. Mutri , S. Giaquinta
10th World Congress on Gastrointestinal Cancer (ESMO International Symposium)
2008
Cetuximab in combination with cisplatin and docetaxel as first-line treatment in patients with locally advanced/metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma (italian phase II docetux study)
F. L. Rojas Llimpe , A. A. Martoni , V. Mutri , S. Giaquinta
10th National Congress of Medical Oncology (AIOM)
5
2008
MULTIDISCIPLINARY MANAGEMENT OF PROSTATE CANCER PATIENTS: THE PERSTEP DATA
G. Morgia , R. Valdagni , S. Bracarda , Giuseppe Martorana
88° Congresso Nazionale SIU
2015
Cetuximab in combination with cisplatin and docetaxel as first-line treatment in patients with locally advanced or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma (Italian phase II DOCETUX study)
C. Pinto , F. Di Fabio , C. Barone , S. Siena
Journal of Clinical Oncology 26 4575 -4575
11
2008
Skin cancer triage and management during COVID-19 pandemic.
L. Tagliaferri , A. Di Stefani , G. Schinzari , B. Fionda
Journal of The European Academy of Dermatology and Venereology 34 ( 6) 1136 -1139
43
2020
Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer.
C. Barone , A. Cassano , C. Pozzo , D. D’Ugo
Oncology 67 ( 1) 48 -53
26
2004
TMZ and PCV in unresectable high grade gliomas: a retrospective comparison between two common schedules
M. Quirino , M. Basso , N. Trigila , E. D’Argento
Journal of Clinical Oncology 23 ( 16_suppl) 1580 -1580
2005
Docetaxel and oxaliplatin combination as second-line treatment in patients with advanced gastric cancer
G. Schinzari , E. D’Argento , M. Quirino , M. Basso
Journal of Clinical Oncology 23 ( 16_suppl) 4188 -4188
14
2005
Nevirapine restores hormone sensitivity in undifferentiated androgen-refractory prostate carcinoma cells
M. Landriscina , C. Bagalà , A. Piscazzi , M. Quirino
Journal of Clinical Oncology 24 13149 -13149
2006
Multimodality treatment of non small cells lung cancer (NSCLC) brain metastases: Long term outcome
A. Cassano , A. Pompucci , E. D’Argento , G. Schinzari
Journal of Clinical Oncology 24 ( 18_suppl) 17046 -17046
1
2006
Long-term follow-up of colorectal cancer (CRC) patients treated with neoadjuvant chemotherapy with irinotecan and fluorouracil plus folinic acid (5-FU/FA) for unresectable liver metastases
C. Pozzo , M. Basso , M. Quirino , G. Schinzari
Journal of Clinical Oncology 24 ( 18_suppl) 3576 -3576
7
2006
Targeted therapy in advanced gastric carcinoma: the future is beginning.
G. Schinzari , A. Cassano , A. Orlandi , M. Basso
Current Medicinal Chemistry 21 ( 8) 1026 -1038
10
2014
Pancreatic neuroendocrine tumors in MEN1 disease: a mono-centric longitudinal and prognostic study
S. Chiloiro , F. Lanza , A. Bianchi , G. Schinzari
Endocrine 60 ( 2) 362 -367
7
2018
E36Resection of lung metastases from colorectal cancer: analysis of outcome and prognostic factors
A. Cassano , M.T. Congedo , E. D'Argento , C. Pozzo
Annals of Oncology 26
2015
P-201 Long term outcome of multimodality treatment of non small cell lung cancer (NSCLC) brain metastases: Experience of eight years
A. Cassano , A. Pompucci , E. D'Argento , G. Schinzari
Lung Cancer 49
2005
S100A13, a new marker of angiogenesis in human astrocytic gliomas.
M. Landriscina , G. Schinzari , G. Di Leonardo , M. Quirino
Journal of Neuro-oncology 80 ( 3) 251 -259
34
2006
48 ACTIVATING MUTATION OF KRAS ONCOGENE AS A PREDICTIVE BIOMARKER OF RESPONSE TO FIRST-LINE CONVENTIONAL CHEMOTHERAPY: A RETROSPECTIVE ANALYSIS
A. Strippoli , A. Orlandi , M. Basso , G. Schinzari
Cancer Treatment Reviews 36
2010
SK3 polyglutamine tract polymorphism and acute oxaliplatin neurotoxicity: A translational study
M. Basso , D. Spada , A. Modoni , A. Cassano
Journal of Clinical Oncology 25 21076 -21076
2007
S78 Can adjuvant radiotherapy improve the outcome of kidney cancer patients
V. Frascino , G. Mantini , G. D’Agostino , A.R. Alitto
European Urology Supplements 8 ( 8) 633 -634
2009